Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 19 August 1994:
Vol. 265. no. 5175, pp. 1059 - 1064
DOI: 10.1126/science.8066444
Prev | Table of Contents | Next

Articles

Science, Vol 265, Issue 5175, 1059-1064
Copyright © 1994 by American Association for the Advancement of Science

articles

Crystal structure of a catalytic antibody with a serine protease active site

GW Zhou, J Guo, W Huang, RJ Fletterick, and TS Scanlan

Department of Biochemistry and Biophysics, University of California, San Francisco 94143-0448.

The three-dimensional structure of an unusually active hydrolytic antibody with a phosphonate transition state analog (hapten) bound to the active site has been solved to 2.5 A resolution. The antibody (17E8) catalyzes the hydrolysis of norleucine and methionine phenyl esters and is selective for amino acid esters that have the natural alpha-carbon L configuration. A plot of the pH-dependence of the antibody-catalyzed reaction is bell-shaped with an activity maximum at pH 9.5; experiments on mechanism lend support to the formation of a covalent acyl-antibody intermediate. The structural and kinetic data are complementary and support a hydrolytic mechanism for the antibody that is remarkably similar to that of the serine proteases. The antibody active site contains a Ser-His dyad structure proximal to the phosphorous atom of the bound hapten that resembles two of the three components of the Ser-His-Asp catalytic triad of serine proteases. The antibody active site also contains a Lys residue to stabilize oxyanion formation, and a hydrophobic binding pocket for specific substrate recognition of norleucine and methionine side chains. The structure identifies active site residues that mediate catalysis and suggests specific mutations that may improve the catalytic efficiency of the antibody. This high resolution structure of a catalytic antibody-hapten complex shows that antibodies can converge on active site structures that have arisen through natural enzyme evolution.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Towards Covalent Vaccination: IMPROVED POLYCLONAL HIV NEUTRALIZING ANTIBODY RESPONSE INDUCED BY AN ELECTROPHILIC gp120 V3 PEPTIDE ANALOG.
Y. Nishiyama, Y. Mitsuda, H. Taguchi, S. Planque, M. Salas, C. V. Hanson, and S. Paul (2007)
J. Biol. Chem. 282, 31250-31256
   Abstract »    Full Text »    PDF »
Mechanistic Analysis of the Phosphonate Transition-state Analogue-derived Catalytic and Non-catalytic Antibody.
Y. Nishi, N. Yamamoto, K. Shimazaki, N. Takahashi-Ando, H. Kakinuma, S. Jialin, S. N. Ruzheinikov, T. A. Muranova, D. W. Rice, and Y. Kajihara (2007)
J. Biochem. 142, 421-433
   Abstract »    Full Text »    PDF »
Model-based mutagenesis to improve the enantioselective fractionation properties of an antibody.
T.K. Nevanen, M.-L. Hellman, N. Munck, G. Wohlfahrt, A. Koivula, and H. Soderlund (2003)
Protein Eng. Des. Sel. 16, 1089-1097
   Abstract »    Full Text »    PDF »
Specific HIV gp120-cleaving Antibodies Induced by Covalently Reactive Analog of gp120.
S. Paul, S. Planque, Y.-X. Zhou, H. Taguchi, G. Bhatia, S. Karle, C. Hanson, and Y. Nishiyama (2003)
J. Biol. Chem. 278, 20429-20435
   Abstract »    Full Text »    PDF »
Broadly Distributed Chemical Reactivity of Natural Antibodies Expressed in Coordination with Specific Antigen Binding Activity.
S. Planque, H. Taguchi, G. Burr, G. Bhatia, S. Karle, Y.-X. Zhou, Y. Nishiyama, and S. Paul (2003)
J. Biol. Chem. 278, 20436-20443
   Abstract »    Full Text »    PDF »
VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease.
Y. BANGALE, S. KARLE, S. PLANQUE, Y.-X. ZHOU, H. TAGUCHI, Y. NISHIYAMA, L. LI, R. KALAGA, and S. PAUL (2003)
FASEB J 17, 628-635
   Abstract »    Full Text »    PDF »
Molecular Evolution of Catalytic Antibodies in Autoimmune Mice.
J. Sun, N. Takahashi, H. Kakinuma, and Y. Nishi (2001)
J. Immunol. 167, 5775-5785
   Abstract »    Full Text »    PDF »
Overpassing an aberrant V{kappa} gene to sequence an anti-idiotypic abzyme with {beta}-lactamase-like activity that could have a linkage with autoimmune diseases.
H. DEBAT, B. AVALLE, O. CHOSE, C.-O. SARDE, A. FRIBOULET, and D. THOMAS (2001)
FASEB J 15, 815-822
   Abstract »    Full Text »    PDF »
Structure of the M{alpha}2-3 toxin {alpha} antibody-antigen complex: combination of modelling with functional mapping experimental results.
C. Tenette-Souaille and J. C. Smith (2000)
Protein Eng. Des. Sel. 13, 345-351
   Abstract »    Full Text »    PDF »
Crystal structure of Taq DNA polymerase in complex with an inhibitory Fab: The Fab is directed against an intermediate in the helix-coil dynamics of the enzyme.
R. Murali, D. J. Sharkey, J. L. Daiss, and H. M. K. Murthy (1998)
PNAS 95, 12562-12567
   Abstract »    Full Text »    PDF »
Immunological Origins of Binding and Catalysis in a Diels-Alderase Antibody.
F. E. Romesberg, B. Spiller, P. G. Schultz, and R. C. Stevens (1998)
Science 279, 1929-1933
   Abstract »    Full Text »
Immune Versus Natural Selection: Antibody Aldolases with Enzymic Rates But Broader Scope.
C. F. Barbas III, A. Heine, G. Zhong, T. Hoffmann, S. Gramatikova, R. Björnestedt, B. List, J. Anderson, E. A. Stura, I. A. Wilson, et al. (1997)
Science 278, 2085-2092
   Abstract »    Full Text »
The Functional Architecture of an Acetylcholine Receptor-mimicking Antibody.
K. Merienne, N. Germain, S. Zinn-Justin, J.-C. Boulain, F. Ducancel, and A. Menez (1997)
J. Biol. Chem. 272, 23775-23783
   Abstract »    Full Text »    PDF »
Phage display of a catalytic antibody to optimize affinity for transition-state analog binding.
M. Baca, T. S. Scanlan, R. C. Stephenson, and J. A. Wells (1997)
PNAS 94, 10063-10068
   Abstract »    Full Text »    PDF »
X-ray structures of a hydrolytic antibody and of complexes elucidate catalytic pathway from substrate binding and transition state stabilization through water attack and product release.
B. Gigant, J.-B. Charbonnier, Z. Eshhar, B. S. Green, and M. Knossow (1997)
PNAS 94, 7857-7861
   Abstract »    Full Text »    PDF »
Crystal structure of varicella-zoster virus protease.
X. Qiu, C. A. Janson, J. S. Culp, S. B. Richardson, C. Debouck, W. W. Smith, and S. S. Abdel-Meguid (1997)
PNAS 94, 2874-2879
   Abstract »    Full Text »    PDF »
Mimicry between Receptors and Antibodies. IDENTIFICATION OF SNAKE TOXIN DETERMINANTS RECOGNIZED BY THE ACETYLCHOLINE RECEPTOR AND AN ACETYLCHOLINE RECEPTOR-MIMICKING MONOCLONAL ANTIBODY.
F. Ducancel, K. Merienne, C. Fromen-Romano, O. Tremeau, L. Pillet, P. Drevet, S. Zinn-Justin, J.-C. Boulain, and A. Menez (1996)
J. Biol. Chem. 271, 31345-31353
   Abstract »    Full Text »    PDF »
Crystal Structure of the V[IMAGE] Domain of a T Cell Antigen Receptor.
B. A. Fields, B. Ober, E. L. Malchiodi, M. I. Lebedeva, B. C. Braden, X. Ysern, J.-K. Kim, X. Shao, E.S. Ward, and R. A. Mariuzza (1995)
Science 270, 1821-1824
   Abstract »    PDF »
From molecular diversity to catalysis: lessons from the immune system.
P. Schultz and R. Lerner (1995)
Science 269, 1835-1842
   Abstract »    PDF »
Enzyme mimicry by the antiidiotypic antibody approach.
A. V. Kolesnikov, A. V. Kozyr, E. S. Alexandrova, F. Koralewski, A. V. Demin, M. I. Titov, B. Avalle, A. Tramontano, S. Paul, D. Thomas, et al. (2000)
PNAS 97, 13526-13531
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)